You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藍帆醫療(002382.SZ)收購瑞士經導管主動脈瓣置換(TAVR)公司NVTAG 100%股權交割完成
格隆匯 06-09 19:29

格隆匯6月9日丨藍帆醫療(002382.SZ)公佈,2020年6月8日,公司及公司在香港設立的全資子公司Bluesail New Valve Technology HK Limited與NVTAG賣方股東共同簽署了《交割確認書》,各方確認:2020年6月8日為本次交易的交割日,各方已按照《股權收購協議》的相關約定進行了交易交割;公司已按照《股權轉讓協議》約定向NVTAG賣方股東一次性支付全部交易價款1.396億歐元和85.10萬瑞士法郎(含起始股權購買價格和股東借款對價以及過渡期內的預估損益和資金利息,不含補充營運資金部分);Bluesail New Valve Technology HK Limited已經成為直接持有NVTAG 100%股權的股東,依法享有法律和公司章程規定的各項股東權利並承擔相應股東義務。NVTAG已成為公司全資子公司,並將納入公司合併報表範圍。

目前,公司正在辦理NVTAG的工商登記變更及其他相關事項,並將根據事件的後續進展情況,按照法律法規的要求,及時履行信息披露義務,提請廣大投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account